Tempus AI (NASDAQ:TEM) Trading 7.3% Higher – Here’s Why

Tempus AI, Inc. (NASDAQ:TEM) was up 7.3% during trading on Friday . The stock traded as high as $51.56 and last traded at $51.50. Approximately 235,872 shares were traded during trading, a decline of 79% from the average daily volume of 1,147,819 shares. The stock had previously closed at $48.01.

Analyst Ratings Changes

Several research firms recently commented on TEM. Longbow Research initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective for the company. JPMorgan Chase & Co. raised their price target on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and boosted their price objective for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. TD Cowen initiated coverage on Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $50.00 price objective on the stock. Finally, Piper Sandler started coverage on Tempus AI in a report on Monday, August 12th. They set a “neutral” rating and a $40.00 target price for the company. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $48.67.

Tempus AI Stock Performance

The company has a quick ratio of 3.52, a current ratio of 3.70 and a debt-to-equity ratio of 4.50. The business’s 50-day moving average price is $52.38.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million for the quarter, compared to analysts’ expectations of $159.10 million. As a group, equities research analysts forecast that Tempus AI, Inc. will post -6.51 EPS for the current fiscal year.

Institutional Trading of Tempus AI

Several institutional investors have recently added to or reduced their stakes in TEM. Sandia Investment Management LP bought a new stake in shares of Tempus AI in the 2nd quarter valued at about $136,000. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in Tempus AI in the 3rd quarter worth approximately $258,000. Renaissance Capital LLC purchased a new position in Tempus AI in the 3rd quarter worth approximately $633,000. Northwestern University purchased a new stake in shares of Tempus AI during the second quarter valued at approximately $491,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Tempus AI during the second quarter valued at approximately $633,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.